Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease

Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease

Ruiling Xu, 1 Junying Wang, 1 Juanjuan Xu, 1 Xiangrong Song, 2 Hai Huang, 2 Yue Feng, 3 Chunmei Fu 1 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xu R, Wang J, Xu J, Song X, Huang H, Feng Y, Fu C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
alzheimer’s disease
rhynchophylline
nanoparticles
blood brain barrier
neuroprotective effect
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/8643d94c34834c3b99968e26c4224e69
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8643d94c34834c3b99968e26c4224e69
record_format dspace
spelling oai:doaj.org-article:8643d94c34834c3b99968e26c4224e692021-12-02T06:42:14ZRhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease1178-2013https://doaj.org/article/8643d94c34834c3b99968e26c4224e692020-02-01T00:00:00Zhttps://www.dovepress.com/rhynchophylline-loaded-mpeg-plga-nanoparticles-coated-with-tween-80-fo-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Ruiling Xu, 1 Junying Wang, 1 Juanjuan Xu, 1 Xiangrong Song, 2 Hai Huang, 2 Yue Feng, 3 Chunmei Fu 1 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, People’s Republic of China; 2State Key Laboratory of Biotherapy/Geriatrics and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, People’s Republic of China; 3College of Pharmacy, Southwest University for Nationalities, Chengdu 610041, People’s Republic of ChinaCorrespondence: Chunmei FuKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, People’s Republic of ChinaEmail fuchunmei@scu.edu.cnPurpose: Alzheimer’s disease (AD) is a growing concern in the modern society. The current drugs approved by FDA are not very promising. Rhynchophylline (RIN) is a major active tetracyclic oxindole alkaloid stem from traditional Chinese medicine uncaria species, which has potential activities beneficial for the treatment of AD. However, the application of rhynchophylline for AD treatment is restricted by the low water solubility, low concentration in brain tissue and low bioavailability. And there is no study of brain-targeting therapy with RIN. In this work, we prepared rhynchophylline loaded methoxy poly (ethylene glycol)–poly (dl-lactide-co-glycolic acid) (mPEG-PLGA) nanoparticles (NPS-RIN), which coupled with Tween 80 (T80) further for brain targeting delivery (T80-NPS-RIN).Methods: Preparation and characterization of T80-NPS-RIN were followed by the detection of transportation across the blood–brain barrier (BBB) model in vitro, biodistribution and neuroprotective effects of nanoparticles.Results: The results indicated T80-NPS-RIN could usefully assist RIN to pass through the BBB to the brain. T80-NPS-RIN treatment regulated the activity of neurons in vitro.Conclusion: The presented data confirmed that rhynchophylline encapsulated mPEG-PLGA nanoparticles coated with Tween 80 could across through the BBB and exhibited efficient neuroprotective effects. The T80-NPS-RIN nanoparticles have a chance to be an alternative drug to the therapy of AD.Keywords: Alzheimer’s disease, rhynchophylline, nanoparticles, blood–brain barrier, neuroprotective effectXu RWang JXu JSong XHuang HFeng YFu CDove Medical Pressarticlealzheimer’s diseaserhynchophyllinenanoparticlesblood brain barrierneuroprotective effectMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 1149-1160 (2020)
institution DOAJ
collection DOAJ
language EN
topic alzheimer’s disease
rhynchophylline
nanoparticles
blood brain barrier
neuroprotective effect
Medicine (General)
R5-920
spellingShingle alzheimer’s disease
rhynchophylline
nanoparticles
blood brain barrier
neuroprotective effect
Medicine (General)
R5-920
Xu R
Wang J
Xu J
Song X
Huang H
Feng Y
Fu C
Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
description Ruiling Xu, 1 Junying Wang, 1 Juanjuan Xu, 1 Xiangrong Song, 2 Hai Huang, 2 Yue Feng, 3 Chunmei Fu 1 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, People’s Republic of China; 2State Key Laboratory of Biotherapy/Geriatrics and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, People’s Republic of China; 3College of Pharmacy, Southwest University for Nationalities, Chengdu 610041, People’s Republic of ChinaCorrespondence: Chunmei FuKey Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, People’s Republic of ChinaEmail fuchunmei@scu.edu.cnPurpose: Alzheimer’s disease (AD) is a growing concern in the modern society. The current drugs approved by FDA are not very promising. Rhynchophylline (RIN) is a major active tetracyclic oxindole alkaloid stem from traditional Chinese medicine uncaria species, which has potential activities beneficial for the treatment of AD. However, the application of rhynchophylline for AD treatment is restricted by the low water solubility, low concentration in brain tissue and low bioavailability. And there is no study of brain-targeting therapy with RIN. In this work, we prepared rhynchophylline loaded methoxy poly (ethylene glycol)–poly (dl-lactide-co-glycolic acid) (mPEG-PLGA) nanoparticles (NPS-RIN), which coupled with Tween 80 (T80) further for brain targeting delivery (T80-NPS-RIN).Methods: Preparation and characterization of T80-NPS-RIN were followed by the detection of transportation across the blood–brain barrier (BBB) model in vitro, biodistribution and neuroprotective effects of nanoparticles.Results: The results indicated T80-NPS-RIN could usefully assist RIN to pass through the BBB to the brain. T80-NPS-RIN treatment regulated the activity of neurons in vitro.Conclusion: The presented data confirmed that rhynchophylline encapsulated mPEG-PLGA nanoparticles coated with Tween 80 could across through the BBB and exhibited efficient neuroprotective effects. The T80-NPS-RIN nanoparticles have a chance to be an alternative drug to the therapy of AD.Keywords: Alzheimer’s disease, rhynchophylline, nanoparticles, blood–brain barrier, neuroprotective effect
format article
author Xu R
Wang J
Xu J
Song X
Huang H
Feng Y
Fu C
author_facet Xu R
Wang J
Xu J
Song X
Huang H
Feng Y
Fu C
author_sort Xu R
title Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
title_short Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
title_full Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
title_fullStr Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
title_full_unstemmed Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
title_sort rhynchophylline loaded-mpeg-plga nanoparticles coated with tween-80 for preliminary study in alzheimer’s disease
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/8643d94c34834c3b99968e26c4224e69
work_keys_str_mv AT xur rhynchophyllineloadedmpegplgananoparticlescoatedwithtween80forpreliminarystudyinalzheimerrsquosdisease
AT wangj rhynchophyllineloadedmpegplgananoparticlescoatedwithtween80forpreliminarystudyinalzheimerrsquosdisease
AT xuj rhynchophyllineloadedmpegplgananoparticlescoatedwithtween80forpreliminarystudyinalzheimerrsquosdisease
AT songx rhynchophyllineloadedmpegplgananoparticlescoatedwithtween80forpreliminarystudyinalzheimerrsquosdisease
AT huangh rhynchophyllineloadedmpegplgananoparticlescoatedwithtween80forpreliminarystudyinalzheimerrsquosdisease
AT fengy rhynchophyllineloadedmpegplgananoparticlescoatedwithtween80forpreliminarystudyinalzheimerrsquosdisease
AT fuc rhynchophyllineloadedmpegplgananoparticlescoatedwithtween80forpreliminarystudyinalzheimerrsquosdisease
_version_ 1718399762385862656

Ejemplares similares